Full Text View
Tabular View
No Study Results Posted
Related Studies
Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)
This study is currently recruiting participants.
Study NCT00591643   Information provided by Memorial Sloan-Kettering Cancer Center
First Received: December 26, 2007   Last Updated: June 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Adrenal Tumors
Adrenal Malignancies
Abnormal Hormonal Secretions
Electrolytes Abnormalities
Additional conditions recognized in this trial
Adrenal Gland Neoplasms
Congenital Abnormalities
Neoplasms
More general conditions related to this trial
Adrenal Gland Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms by Site
Interventions listed in this trial
Imaging, Adrenal acans
Additional drug interventions recognized in this trial
Epinephrine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Mydriatics
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services